Bo Song, Tong Xiao, Xiaolu Qi, Ling-Na Li, Kuiyou Qin, Siyun Nian, Guo-Xin Hu, Yinfei Yu, Guang Liang, Faqing Ye
Index: Bioorg. Med. Chem. Lett. 22(4) , 1739-42, (2012)
Full Text: HTML
Monoamine oxidase-B (MAO-B) inhibitor has been used as neuroprotectants to treat the motor deficits of Parkinson's disease (PD). We designed and synthesized a class of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors. The compounds have various inhibitory effects, with compound 6a having a K(i) value of 0.26 μM. Their promising activity in vitro suggests potential use in the treatment of PD.Copyright © 2012 Elsevier Ltd. All rights reserved.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Istradefylline
CAS:155270-99-8 |
C20H24N4O4 |
|
On the role of adenosine (A)₂A receptors in cocaine-induced ...
2015-01-01 [Psychopharmacol. Ser. 232(2) , 421-35, (2015)] |
|
Haloperidol promotes mTORC1-dependent phosphorylation of rib...
2013-09-01 [Neuropharmacology 72 , 197-203, (2013)] |
|
Effects of the adenosine A 2A antagonist KW 6002 (istradefyl...
2009-09-29 [Neuroscience 163(1) , 97-108, (2009)] |
|
Differential effects of presynaptic versus postsynaptic aden...
2014-05-07 [J. Neurosci. 34(19) , 6480-4, (2014)] |
|
Population pharmacokinetic analysis of istradefylline in hea...
2011-01-01 [J. Clin. Pharmacol. 51(1) , 40-52, (2011)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
